ArticleBritish journal of cancer2015

Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours.

M Beloueche-Babari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.